February can be one of most volatile months for ASX 200 shares as investors and brokers react to earnings results.
But once the dust settles, it's important to review buying opportunities from companies that were potentially oversold.
It's important to mention there's no guarantee these shares bounce back, and there are reasons investors decided to move on.
However, on the flip side, those with a long term view could consider this an attractive entry point.
With that in mind, here are some ASX 200 shares that could be undervalued right now after big sell-offs.
Image source: Getty Images
REA Group Ltd (ASX: REA)
REA shares are down more than 13% over the last month and 32% over the last year.
This included a crash after the company released H1 FY26 results in early February.
REA group has divided experts, as some have tipped a rebound due to AI fears being overblown, while others have warned to stay away.
For investors who are more confident in a bounceback due to the company's market share, now could be an attractive time to buy.
Bell Potter sees this as a possibility. The broker has a $211 price target on REA shares which indicates an upside of roughly 27%.
Zip Co Ltd (ASX: ZIP)
For investors looking for ASX 200 shares that could be trading at a value, Zip could also be an option.
Zip Co was another ASX 200 company that endured a crash on the back of earnings results.
Its share price is now down more than 47% year to date.
It's worth noting that after earnings results, UBS confirmed a buy rating on Zip shares and a $4.50 target price.
This is more than 150% higher from yesterday's closing price.
CSL Ltd (ASX: CSL)
CSL is the largest ASX 200 healthcare company by some margin.
However it has been one of the worst performing amongst the sector lately.
Its share price is down 14% year to date and almost 44% in the last 12 months.
It reported half-year results on February 11, which led to a 12% share price crash.
The combination of poor results and a CEO exit weighed heavily on sentiment.
However these ASX 200 shares might have been oversold.
Ord Minnett cut its target price for the healthcare giant following results to $198.00.
However that still indicates approximately 34% upside from current levels.
WiseTech Global Ltd (ASX: WTC)
WiseTech shares actually jumped higher on earnings results late last month.
However its share price is still down almost 34% year to date.
It has been one of the many tech shares suffering from fears around AI.
Experts seem to be projecting a recovery.
Bell Potter and UBS have price targets of $83.70 and $89 respectively.
This would be an increase between 80% and 96%, however it is worth noting these targets are much lower than they had been previously.
